PN,31301
SC,0001
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FThe new treatment offers those who
OL,7,Fsuffer from a life-limiting blood
OL,8,Fdisorder a chance to live without
OL,9,Fneeding regular blood transfusions
OL,11,FHundreds of people in England with a
OL,12,Flife-limiting blood disorder are set
OL,13,Fto benefit from a world-first gene-
OL,14,Fediting therapy after it was given the
OL,15,Fgreen light for NHS use.
OL,17,FHealth bosses hailed the decision by
OL,18,Fthe National Institute for Health and
OL,19,FCare Excellence (NICE) as a "historic
OL,20,Fmoment" for patients with the
OL,21,Fcondition.
OL,26,@{D@]OU|D@GO]
OL,1,W~k4~sj5j5~s1G                    G1/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31302
SC,0002
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FSold as Casgevy, the treatment has
OL,7,Fbeen recommended by NICE to treat
OL,8,Fpatients aged 12 and over the
OL,9,Ftransfusion-dependent beta thalassemia
OL,10,F(TDT) which can lead to severe anaemia.
OL,12,FAccording to the NHS, around 17,000
OL,13,Fpeople live with the disease, with 250
OL,14,Fnew cases each year. It is more common
OL,15,Fin people of Black African, Caribbean,
OL,16,FMiddle Eastern and South Asian
OL,17,Fheritage.
OL,19,FThose who suffer from the inherited
OL,20,Fcondition rely on regular lifelong
OL,21,Fblood transfusions to survive.
OL,1,W~k4~sj5j5~s1G                    G2/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31303
SC,0003
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FThe only curative treatment currently
OL,7,Favailable for people with sickle cell
OL,8,Fin the UK is a donor stem cell
OL,9,Ftransplant, so Casgevy is an option
OL,10,Ffor patients when a stem cell
OL,11,Ftransplant is suitable but no donor
OL,12,Fcan be found.
OL,14,FCasgevy works by modifying the faulty
OL,15,Fgene in a patient's bone marrow stem
OL,16,Fcells so the body produces functioning
OL,17,Fhaemoglobin - the protein found in red
OL,18,Fblood cells that carries oxygen in
OL,19,Fyour body and gives blood its red
OL,20,Fcolour. The edited cells are then
OL,21,Finfused back into the patient.
OL,1,W~k4~sj5j5~s1G                    G3/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31304
SC,0004
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FIt was developed through a partnership
OL,7,Fbetween Vertex Pharmaceuticals and
OL,8,FCrispr Therapeutics and is licensed
OL,9,Fusing the gene-editing tool Crispr -
OL,10,Ftechnology which earned its inventors
OL,11,Fthe Nobel Prize for chemistry in 2020.
OL,13,FAccording to the Nice guidance, the
OL,14,Flist price for a course of Casgevy is
OL,15,F#1.65 million. However, it is
OL,16,Favailable to the NHS at a discount due
OL,17,Fto a commercial agreement with the
OL,18,Fhealth service. It will be funded
OL,19,Fimmediately and rolled out to up to
OL,20,F460 eligible patients.
OL,1,W~k4~sj5j5~s1G                    G4/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31305
SC,0005
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FSubscribe free to our weekly
OL,7,Fnewsletter for exclusive and original
OL,8,Fcoverage from ITV News. Direct to your
OL,9,Finbox every Friday morning.
OL,11,FAmanda Pritchard, NHS England chief
OL,12,Fexecutive, said: "Ordinarily, patients
OL,13,Fexperience painful side effects and
OL,14,Fundergo regular transfusions which
OL,15,Fseverely impact their quality of life,
OL,16,Fbut this therapy offers people a life
OL,17,Ffree from that as well as the hope of
OL,18,Fliving longer, which is truly amazing
OL,19,Fnews.
OL,26,@tD@ROU
OL,1,W~k4~sj5j5~s1G                    G5/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31306
SC,0006
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,F"This is the latest in a series of
OL,7,Frevolutionary gene therapies to be
OL,8,Fsecured by NHS England over the past
OL,9,Ffive years, bringing significant
OL,10,Fbenefit for patients."
OL,12,FHelen Knight, director of medicines
OL,13,Fevaluation at NICE, added: "Although
OL,14,Fthere are some uncertainties in the
OL,15,Fevidence for its long-term benefits,
OL,16,Fthe committee felt (Casgevy) could
OL,17,Frepresent a potential cure for some
OL,18,Fpeople with TDT."
OL,26,@nD@AOUuD@\OUxD@TpmxD@\pnzD@QOU
OL,1,W~k4~sj5j5~s1G                    G6/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31307
SC,0007
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FKirthana Balachandran, 21, from West
OL,7,FLondon, was diagnosed with TDT when
OL,8,Fshe was three months old.
OL,10,FThe medical student said: "I
OL,11,Fconstantly worry about the future and
OL,12,Fwhat blood transfusions would be like
OL,13,Fwhen I'm older and how I will manage
OL,14,Fmy condition. With gene therapy, I
OL,15,Fwouldn't have to worry about the side
OL,16,Feffects of blood transfusions and the
OL,17,Freactions I could have, such as iron
OL,18,Fdepositing in my heart and liver."
OL,26,@rD@[OUzD@bO]
OL,1,W~k4~sj5j5~s1G                    G7/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
PN,31308
SC,0008
CT,2,C
PS,c000
OL,0,        ECIMSBWebfax     F313A1723185730
OL,3,CWorld-first gene-editing therapy for
OL,4,Cblood disorders approved for NHS use
OL,6,FLudovic Fenaux, senior vice president
OL,7,Fat Vertex International, said:
OL,8,F"Through collaboration with NHS
OL,9,FEngland and Nice, we have reached this
OL,10,Flandmark agreement that recognises the
OL,11,Fvalue a one-time treatment can provide
OL,12,Fto patients, their families and the
OL,13,Fhealthcare system."
OL,26,@pD@AOUuD@SO]
OL,1,W~k4~sj5j5~s1G                    G8/8
OL,2,W/*%+,"-/.!,.!T,,,,,,,,,,,,,,,,,,,,,,,,,
OL,23,TppppppppppppppppppGsource: itv.com/news
OL,24,ANext Page BNat News CNat TV FClean Feed
FL,314,300,200,140,000,100
